These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 25551472)
1. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells. Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472 [TBL] [Abstract][Full Text] [Related]
2. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics. Li D; Su D; Xue L; Liu Y; Pang W Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318 [TBL] [Abstract][Full Text] [Related]
4. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269 [TBL] [Abstract][Full Text] [Related]
5. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells. Wei X; He J; Wang J; Yang X; Ma B Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615 [TBL] [Abstract][Full Text] [Related]
6. Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Xue Z; Zhou Y; Wang C; Zheng J; Zhang P; Zhou L; Wu L; Shan Y; Ye M; He Y; Cai Z Oncol Rep; 2016 Jan; 35(1):50-8. PubMed ID: 26530530 [TBL] [Abstract][Full Text] [Related]
7. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma. Zhang L; Li H; Ge C; Li M; Zhao FY; Hou HL; Zhu MX; Tian H; Zhang LX; Chen TY; Jiang GP; Xie HY; Cui Y; Yao M; Li JJ Oncotarget; 2014 Nov; 5(21):10621-35. PubMed ID: 25301737 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells. Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785 [TBL] [Abstract][Full Text] [Related]
10. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Ma L; Lai D; Liu T; Cheng W; Guo L Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681 [TBL] [Abstract][Full Text] [Related]
12. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Piao LS; Hur W; Kim TK; Hong SW; Kim SW; Choi JE; Sung PS; Song MJ; Lee BC; Hwang D; Yoon SK Cancer Lett; 2012 Feb; 315(2):129-37. PubMed ID: 22079466 [TBL] [Abstract][Full Text] [Related]
13. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [TBL] [Abstract][Full Text] [Related]
14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Le H; Zeng F; Xu L; Liu X; Huang Y Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862 [TBL] [Abstract][Full Text] [Related]
15. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties]. Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028 [TBL] [Abstract][Full Text] [Related]
16. [Lentivirus-mediated RNA interference of CD133 inhibits the proliferation of CD133(+) liver cancer stem cells and increases their cisplatin chemosensitivity]. Lan X; Wang Y; Cao S; Zou D; Li F; Li S Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1741-7. PubMed ID: 23268401 [TBL] [Abstract][Full Text] [Related]
17. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism]. Lin F; Yan W; Wen T; Wu GY Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Wei C; Guomin W; Yujun L; Ruizhe Q Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251 [TBL] [Abstract][Full Text] [Related]
19. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy. Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620 [TBL] [Abstract][Full Text] [Related]
20. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]